Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical and Vaccine Immunology

• Publication date

  2016-05-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CVI.00248-16PMID 27226279PMCID PMC4933781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli

  2015cited by this paper
• Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED).

  2015cited by this paper
• Vaccines against enteric infections for the developing world

  2015cited by this paper
• Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.

  2014cited by this paper
• Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system

  2014cited by this paper
• Antigen-Specific Memory B-cell Responses to Enterotoxigenic Escherichia coli Infection in Bangladeshi Adults

  2014cited by this paper
• The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof.

  2014cited by this paper
• Novel antigens for enterotoxigenic Escherichia coli vaccines

  2014cited by this paper
• Intradermal Delivery of Shigella IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes

  2014cited by this paper
• Shift in Phenotypic Characteristics of Enterotoxigenic Escherichia coli (ETEC) Isolated from Diarrheal Patients in Bangladesh

  2014cited by this paper
• Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution

  2014cited by this paper
• Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.

  2013cited by this paper
• DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults.

  2013cited by this paper
• Secretory IgA: Designed for Anti-Microbial Defense

  2013cited by this paper
• Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.

  2012cited by this paper
• Recent progress toward an enterotoxigenic Escherichia coli vaccine

  2012cited by this paper
• Cooperative Role of Antibodies against Heat-Labile Toxin and the EtpA Adhesin in Preventing Toxin Delivery and Intestinal Colonization by Enterotoxigenic Escherichia coli

  2012cited by this paper
• Study of Avidity of Antigen-Specific Antibody as a Means of Understanding Development of Long-Term Immunological Memory after Vibrio cholerae O1 Infection

  2012cited by this paper
• Devices for intradermal vaccination.

  2012cited by this paper
• The Oral, Live Attenuated Enterotoxigenic Escherichia coli Vaccine ACE527 Reduces the Incidence and Severity of Diarrhea in a Human Challenge Model of Diarrheal Disease

  2012cited by this paper
• A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression.

  2011cited by this paper
• Distribution of Classical and Nonclassical Virulence Genes in Enterotoxigenic Escherichia coli Isolates from Chilean Children and tRNA Gene Screening for Putative Insertion Sites for Genomic Islands

  2011cited by this paper
• Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

  2011cited by this paper
• Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

  2010cited by this paper
• A Comparative Genomic Analysis of Diverse Clonal Types of Enterotoxigenic Escherichia coli Reveals Pathovar-Specific Conservation

  2010cited by this paper
• Control systems and decision making for antibody production

  2010cited by this paper
• Enterotoxigenic Escherichia coli Elicits Immune Responses to Multiple Surface Proteins

  2010cited by this paper
• Global etiology of travelers' diarrhea: systematic review from 1973 to the present.

  2009cited by this paper
• Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

  2009cited by this paper
• Purification of recombinant high molecular weight two-partner secretion proteins from Escherichia coli

  2009cited by this paper
• What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?

  2009cited by this paper
• Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

  2009cited by this paper
• Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model.

  2009cited by this paper
• The Pangenome Structure of Escherichia coli: Comparative Genomic Analysis of E. coli Commensal and Pathogenic Isolates

  2008cited by this paper
• Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells

  2008cited by this paper
• Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.

  2008cited by this paper
• Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

  2008cited by this paper
• The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection

  2008cited by this paper
• Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.

  2007cited by this paper
• Importance of Heat-Labile Enterotoxin in Colonization of the Adult Mouse Small Intestine by Human Enterotoxigenic Escherichia coli Strains

  2006cited by this paper
• Directed delivery of heat‐labile enterotoxin by enterotoxigenic Escherichia coli

  2006cited by this paper
• Identification of a Two-Partner Secretion Locus of Enterotoxigenic Escherichia coli

  2006cited by this paper
• Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G.

  2005cited by this paper
• A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.

  2005cited by this paper
• Efficacy of an acellular pertussis vaccine among adolescents and adults.

  2005cited by this paper
• Protollin: a novel adjuvant for intranasal vaccines.

  2004cited by this paper
• Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.

  2004cited by this paper
• A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles

  2003cited by this paper
• Phenotypic Diversity of EnterotoxigenicEscherichia coli Strains from a Community-Based Study of Pediatric Diarrhea in Periurban Egypt

  1999cited by this paper
• Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides

  1999cited by this paper
• Analysis of Mumps Vaccine Failure by Means of Avidity Testing for Mumps Virus-Specific Immunoglobulin G

  1998cited by this paper
• Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

  1998cited by this paper
• DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

  1997cited by this paper
• Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence.

  1989cited by this paper
• Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay.

  1980cited by this paper
• Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans

  1975cited by this paper
• Three Characteristics Associated with Enterotoxigenic Escherichia coli Isolated from Man

  1973cited by this paper
• Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease.

  1971cited by this paper

• Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization

  2025cites this paper
• Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic Escherichia coli in healthy Bangladeshi adults delivered by three different routes

  2025cites this paper
• Conserved antigens for enteric vaccines

  2025cites this paper
• Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin

  2024cites this paper
• Challenges and Considerations in Selecting Animal Models for Evaluating a Live, Cold-Chain-Free, Dual-Use Vaccine (MyChol) for Diarrhoeal Diseases: A Comprehensive Review

  2024cites this paper
• Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin

  2024cites this paper
• Host-derived CEACAM-laden vesicles engage enterotoxigenic E. coli for elimination and toxin neutralization

  2024cites this paper
• Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines

  2023cites this paper
• The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin

  2023cites this paper
• Non-mucosal vaccination strategies to enhance mucosal immunity.

  2023cites this paper
• Developments in oral enterotoxigenic Escherichia coli vaccines.

  2023cites this paper
• Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic Escherichia coli (ETEC) Challenge in BALB/c Mice

  2022influential citation
• Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge

  2021cites this paper
• Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease

  2021cites this paper
• Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development

  2021cites this paper
• Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge

  2021cites this paper
• U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge

  2020cites this paper
• Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli

  2020cites this paper
• Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments

  2020cites this paper
• Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice

  2019cites this paper
• Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli

  2019cites this paper
• A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.

  2019cites this paper
• Conservation and global distribution of non-canonical antigens in Enterotoxigenic Escherichia coli

  2019cites this paper
• Comparative genomic analysis and molecular examination of the diversity of enterotoxigenic Escherichia coli isolates from Chile

  2019cites this paper
• A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform

  2018cites this paper
• The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT

  2018cites this paper
• Interplay of a secreted protein with type IVb pilus for efficient enterotoxigenic Escherichia coli colonization

  2018cites this paper
• Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform

  2018cites this paper
• Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity

  2018cites this paper
• Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

  2017cites this paper
• Maternal Vaccination. Immunization of Sows during Pregnancy against ETEC Infections

  2017cites this paper
• Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery

  2016cites this paper